Acne scar ablative CO2 laser postoperative
Conditions
Interventions
Experimental group:Fusidic acid
Control group:Erythromycin
Sponsors
Plastic Surgery hospital, Peking Union Medical College and Chinese Academy of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: 1. Willing to participate in this trial, can adhere to medication, prohibit combined medication and timely follow-up; 2. aged 16~70 years old male and female; 3. Patients with facial and neck acne scars treated with carbon dioxide laser or holmium laser.
Exclusion criteria
Exclusion criteria: 1. Had been participated in other clinical trial within 4 weeks before the start of the study; 2. The subjects who have been treated with dot laser treatment, have a history of sun exposure or a history of photosensitizing drugs; 3. Fusidic acid, erythromycin drugs, allergic to any of its preparations; 4. Pregnant or lactating women, have obvious endocrine system diseases, mental illness, blood diseases, liver and kidney disease, patients with cardiovascular and cerebrovascular diseases, immune dysfunction and bleeding tendency; 5. suffering from other facial skin diseases may interfere with the efficacy of the judgment: such as solar dermatitis, facial psoriasis, facial seborrheic dermatitis, facial eczema, etc.; 5. Need to combine system use or facial antibiotics, corticosteroids, retinoids, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| acne scar; | — |
Countries
China
Contacts
Public ContactBaoxi Wang
Plastic Surgery hospital, Peking Union Medical College and Chinese Academy of Medical Sciences
Outcome results
None listed